Iodide

Iodide

SCHEMBL5792092

CC[n+]1cccc(Cn2c(-c3ccccc3C)nc3ccc(Oc4ccc(F)cc4)cc3c2=O)c1.[I-]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ GHSR Q92847 3/20 0.55
▸ CYP2D6 P10635 3/20 0.52
▸ CASR P41180 5/20 0.43
▸ KCNH2 Q12809 1/20 0.39
▸ BRD4 O60885 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ F11 P03951 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TDO2 P48775 1/20 0.36
▸ IDO2 Q6ZQW0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5792113 0.82 GHSR (0.59) GHSRCYP2D6CASRKCNH2BRD4
SCHEMBL5819936 0.75 GHSR (0.58) GHSRCYP2D6CASRKCNH2TDO2
SCHEMBL5792841 0.74 GHSR (0.65) GHSRCYP2D6CASRKCNH2
SCHEMBL5791517 0.71 GHSR (0.75) GHSRCYP2D6CASRKCNH2TDO2
SCHEMBL12788321 0.70 POLB (0.59) GHSRCYP2D6KCNH2POLBSMN1; SMN2
SCHEMBL6308155 0.70 BRD4 (0.47) GHSRCYP2D6BRD4F11SMN1; SMN2
SCHEMBL5823984 0.69 CYP2D6 (0.76) GHSRCYP2D6KCNH2
SCHEMBL6309011 0.65 CASR (0.51) CASRSMN1; SMN2
SCHEMBL12789762 0.65 CYP2D6 (0.47) GHSRCYP2D6CASRKCNH2POLB
SCHEMBL12789754 0.65 CYP2D6 (0.47) GHSRCYP2D6CASRKCNH2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006012577-A2 QUINAZOLINONE DERIVATIVES USEFUL FOR THE REGULATION OF GLUCOSE HOMEOSTASIS AND FOOD INTAKE BAYER PHARMACEUTICALS CORPORATION (US) 2006-02-02 — — WO disclosed
Send feedback